atenolol has been researched along with levetiracetam in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bayles, J; Chen, YS; Daphna-Iken, D; Fisher, SJ; Reno, CM; Skinner, A | 1 |
Blair, RE; DeLorenzo, RJ; Deshpande, LS; Halquist, M; Kosmider, L | 1 |
Erdem, ÇE; Eroğlu, H; Eylem, CC; Gökmen-Özel, H; Ilgaz, F; Nemutlu, E; Timur, SS | 1 |
1 review(s) available for atenolol and levetiracetam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for atenolol and levetiracetam
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Severe hypoglycemia-induced sudden death is mediated by both cardiac arrhythmias and seizures.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Arrhythmias, Cardiac; Atenolol; Death, Sudden, Cardiac; Drug Therapy, Combination; Electrocardiography; Hypoglycemia; Levetiracetam; Male; Rats; Rats, Sprague-Dawley; Seizures | 2018 |
Intramuscular atenolol and levetiracetam reduce mortality in a rat model of paraoxon-induced status epilepticus.
Topics: Administration, Oral; Animals; Atenolol; Injections, Intramuscular; Levetiracetam; Male; Paraoxon; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2020 |
Do Thickening Agents Used in Dysphagia Diet Affect Drug Bioavailability?
Topics: Animals; Atenolol; Biological Availability; Carbamazepine; Cefixime; Chromatography, Liquid; Deglutition Disorders; Diet; Food Additives; Humans; Levetiracetam; Plant Nectar; Rabbits; Starch; Tablets; Tandem Mass Spectrometry; Viscosity; Water | 2022 |